Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Brain-derived neurotrophic factor levels in pediatric sickle cell disease.

Lance EI, Barron-Casella E, Everett AD, Casella JF.

Pediatr Blood Cancer. 2020 Feb;67(2):e28076. doi: 10.1002/pbc.28076. Epub 2019 Nov 17.

PMID:
31736231
2.

Male reproductive health in cystic fibrosis.

Yoon JC, Casella JL, Litvin M, Dobs AS.

J Cyst Fibros. 2019 Oct;18 Suppl 2:S105-S110. doi: 10.1016/j.jcf.2019.08.007.

3.

Ectopic Cushing Syndrome: A Rare Cause of Electrolyte Derangements.

Fanous N, Schwartz C, Gargus N, Casella JL.

Am J Med. 2019 Oct 10. pii: S0002-9343(19)30802-2. doi: 10.1016/j.amjmed.2019.08.047. [Epub ahead of print] No abstract available.

PMID:
31606493
4.

Quantification of whole-brain oxygenation extraction fraction and cerebral metabolic rate of oxygen consumption in adults with sickle cell anemia using individual T2 -based oxygenation calibrations.

Li W, Xu X, Liu P, Strouse JJ, Casella JF, Lu H, van Zijl PCM, Qin Q.

Magn Reson Med. 2020 Mar;83(3):1066-1080. doi: 10.1002/mrm.27972. Epub 2019 Sep 4.

PMID:
31483528
5.

Correlates of successful transition in young adults with sickle cell disease.

Darbari I, Jacobs E, Gordon O, Weiss D, Winship K, Casella JF, Strouse JJ, Takemoto CM.

Pediatr Blood Cancer. 2019 Dec;66(12):e27939. doi: 10.1002/pbc.27939. Epub 2019 Aug 20.

PMID:
31429531
6.

Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.

Casella JF, Adams RJ, Brambilla DJ, Strouse JJ, Maier P, Dlugash R, Avadhani R, Vermillion K, Tonascia J, Voeks JH, Hanley DF, Thompson RE, Lehmann HP.

Clin Trials. 2019 Feb;16(1):20-31. doi: 10.1177/1740774518807160. Epub 2018 Nov 14.

PMID:
30426764
7.

Progressive loss of brain volume in children with sickle cell anemia and silent cerebral infarct: A report from the silent cerebral infarct transfusion trial.

Darbari DS, Eigbire-Molen O, Ponisio MR, Milchenko MV, Rodeghier MJ, Casella JF, McKinstry RC, DeBaun MR.

Am J Hematol. 2018 Dec;93(12):E406-E408. doi: 10.1002/ajh.25297. Epub 2018 Oct 26. No abstract available.

8.

BRAZIL ROAD-KILL: a data set of wildlife terrestrial vertebrate road-kills.

Grilo C, Coimbra MR, Cerqueira RC, Barbosa P, Dornas RAP, Gonçalves LO, Teixeira FZ, Coelho IP, Schmidt BR, Pacheco DLK, Schuck G, Esperando IB, Anza JA, Beduschi J, Oliveira NR, Pinheiro PF, Bager A, Secco H, Guerreiro M, Carvalho CF, Veloso AC, Custódio AEI, Marçal O Jr, Ciocheti G, Assis J, Ribeiro MC, Francisco BSS, Cherem JJ, Trigo TC, Jardim MMA, Franceschi IC, Espinosa C, Tirelli FP, Rocha VJ, Sekiama ML, Barbosa GP, Rossi HR, Moreira TC, Cervini M, Rosa CA, Silva LG, Ferreira CMM, César A, Casella J, Mendes SL, Zina J, Bastos DFO, Souza RAT, Hartmann PA, Deffaci ACG, Mulinari J, Luzzi SC, Rezzadori T, Kolcenti C, Reis TX, Fonseca VSC, Giorgi CF, Migliorini RP, Kasper CB, Bueno C, Sobanski M, Pereira APFG, Andrade FAG, Fernandes MEB, Corrêa LLC, Nepomuceno A, Banhos A, Hannibal W, Fonseca R, Costa LA, Medici EP, Croce A, Werther K, Oliveira JP, Ribeiro JM, de Santi M, Kawanami AE, Perles L, do Couto C, Figueiró DS, Eizirik E, Correia AA Jr, Corrêa FM, Queirolo D, Quagliatto AL, Saranholi BH, Galetti PM Jr, Rodriguez-Castro KG, Braz VS, França FGR, Buss G, Rezini JA, Lion MB, Cheida CC, Lacerda ACR, Freitas CH, Venâncio F, Adania CH, Batisteli AF, Hegel CGZ, Mantovani JA, Rodrigues FHG, Bagatini T, Curi NHA, Emmert L, Erdmann RH, Costa RRGF, Martinelli A, Santos CVF, Kindel A.

Ecology. 2018 Nov;99(11):2625. doi: 10.1002/ecy.2464. Epub 2018 Sep 19.

PMID:
30229895
9.

The inducible chemical-genetic fluorescent marker FAST outperforms classical fluorescent proteins in the quantitative reporting of bacterial biofilm dynamics.

Monmeyran A, Thomen P, Jonquière H, Sureau F, Li C, Plamont MA, Douarche C, Casella JF, Gautier A, Henry N.

Sci Rep. 2018 Jul 9;8(1):10336. doi: 10.1038/s41598-018-28643-z.

10.
11.

Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes.

Jordan LC, Roberts Williams DO, Rodeghier MJ, Covert Greene BV, Ponisio MR, Casella JF, McKinstry RC, Noetzel MJ, Kirkham FJ, Meier ER, Fuh B, McNaull M, Sarnaik S, Majumdar S, McCavit TL, DeBaun MR.

Am J Hematol. 2018 Jun;93(6):760-768. doi: 10.1002/ajh.25085. Epub 2018 Mar 30.

12.

Diagnostic utility of telomere length testing in a hospital-based setting.

Alder JK, Hanumanthu VS, Strong MA, DeZern AE, Stanley SE, Takemoto CM, Danilova L, Applegate CD, Bolton SG, Mohr DW, Brodsky RA, Casella JF, Greider CW, Jackson JB, Armanios M.

Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2358-E2365. doi: 10.1073/pnas.1720427115. Epub 2018 Feb 20. Erratum in: Proc Natl Acad Sci U S A. 2018 Apr 23;:.

13.

Non-volant mammals from the Upper Paraná River Basin: a data set from a critical region for conservation in Brazil.

Gonçalves F, Hannibal W, Godoi MN, Martins FI, Oliveira RF, Figueiredo VV, Casella J, de Sá ÉFGG.

Ecology. 2018 Feb;99(2):499. doi: 10.1002/ecy.2107. Epub 2018 Jan 17.

PMID:
29341115
14.

Identification of Aptamers That Bind to Sickle Hemoglobin and Inhibit Its Polymerization.

Purvis SH, Keefer JR, Fortenberry YM, Barron-Casella EA, Casella JF.

Nucleic Acid Ther. 2017 Dec;27(6):354-364. doi: 10.1089/nat.2016.0646. Epub 2017 Oct 17.

PMID:
29039727
15.

Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia.

Chaturvedi S, Bhatnagar P, Bean CJ, Steinberg MH, Milton JN, Casella JF, Barron-Casella E, Arking DE, DeBaun MR.

Blood. 2017 Aug 3;130(5):686-688. doi: 10.1182/blood-2017-02-769661. Epub 2017 Jun 5. No abstract available.

16.

High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Gamper CJ, Takemoto CM, Chen AR, Symons HJ, Loeb DM, Casella JF, Dezern AE, King KE, McGonigle AM, Jones RJ, Brodsky RA.

J Pediatr Hematol Oncol. 2016 Nov;38(8):627-635.

17.

Widespread Pain Among Youth With Sickle Cell Disease Hospitalized With Vasoocclusive Pain: A Different Clinical Phenotype?

Zempsky WT, Wakefield EO, Santanelli JP, New T, Smith-Whitley K, Casella JF, Palermo TM.

Clin J Pain. 2017 Apr;33(4):335-339. doi: 10.1097/AJP.0000000000000403.

PMID:
27322398
18.

Newborn Screening Programs and Sickle Cell Disease: A Public Health Services and Systems Approach.

Minkovitz CS, Grason H, Ruderman M, Casella JF.

Am J Prev Med. 2016 Jul;51(1 Suppl 1):S39-47. doi: 10.1016/j.amepre.2016.02.019.

19.

Stereotyped spatial patterns of functional synaptic connectivity in the cerebellar cortex.

Valera AM, Binda F, Pawlowski SA, Dupont JL, Casella JF, Rothstein JD, Poulain B, Isope P.

Elife. 2016 Mar 16;5. pii: e09862. doi: 10.7554/eLife.09862.

20.

Preventive Care Delivery to Young Children With Sickle Cell Disease.

Bundy DG, Muschelli J, Clemens GD, Strouse JJ, Thompson RE, Casella JF, Miller MR.

J Pediatr Hematol Oncol. 2016 May;38(4):294-300. doi: 10.1097/MPH.0000000000000537.

21.

Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease.

Lance EI, Comi AM, Johnston MV, Casella JF, Shapiro BK.

Clin Pediatr (Phila). 2015 Oct;54(11):1087-93. doi: 10.1177/0009922815594356. Epub 2015 Jul 6.

22.

Impact of simulation training on self-efficacy of outpatient health care providers to use electronic health records.

Vuk J, Anders ME, Mercado CC, Kennedy RL, Casella J, Steelman SC.

Int J Med Inform. 2015 Jun;84(6):423-9. doi: 10.1016/j.ijmedinf.2015.02.003. Epub 2015 Feb 19.

PMID:
25746460
23.

Transcranial Doppler screening of Medicaid-insured children with sickle cell disease.

Bundy DG, Abrams MT, Strouse JJ, Mueller CH, Miller MR, Casella JF.

J Pediatr. 2015 Jan;166(1):188-90. doi: 10.1016/j.jpeds.2014.09.018. Epub 2014 Oct 14.

PMID:
25444529
24.

Transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Casella JF.

N Engl J Med. 2014 Nov 6;371(19):1841-2. doi: 10.1056/NEJMc1411133. No abstract available.

PMID:
25372094
25.

Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy.

Beverung LM, Strouse JJ, Hulbert ML, Neville K, Liem RI, Inusa B, Fuh B, King A, Meier ER, Casella J, DeBaun MR, Panepinto JA; SIT trial investigators.

Am J Hematol. 2015 Feb;90(2):139-43. doi: 10.1002/ajh.23877.

26.

Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Lance EI, Casella JF, Everett AD, Barron-Casella E.

Proteomics Clin Appl. 2014 Dec;8(11-12):813-27. doi: 10.1002/prca.201400069. Epub 2014 Nov 6. Review.

27.

Development and validation of the Youth Acute Pain Functional Ability Questionnaire (YAPFAQ).

Zempsky WT, O'Hara EA, Santanelli JP, New T, Smith-Whitley K, Casella J, Palermo TM.

J Pain. 2014 Dec;15(12):1319-27. doi: 10.1016/j.jpain.2014.09.008. Epub 2014 Sep 30.

28.

Immunologic effects of hydroxyurea in sickle cell anemia.

Lederman HM, Connolly MA, Kalpatthi R, Ware RE, Wang WC, Luchtman-Jones L, Waclawiw M, Goldsmith JC, Swift A, Casella JF; BABY HUG Investigators.

Pediatrics. 2014 Oct;134(4):686-95. doi: 10.1542/peds.2014-0571. Epub 2014 Sep 1.

29.

Hydroxyurea and growth in young children with sickle cell disease.

Rana S, Houston PE, Wang WC, Iyer RV, Goldsmith J, Casella JF, Reed CK, Rogers ZR, Waclawiw MA, Thompson B; BABY HUG Investigators.

Pediatrics. 2014 Sep;134(3):465-72. doi: 10.1542/peds.2014-0917. Erratum in: Pediatrics. 2015 Sep;136(3):584.

30.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

31.

Silent cerebral infarction, income, and grade retention among students with sickle cell anemia.

King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR.

Am J Hematol. 2014 Oct;89(10):E188-92. doi: 10.1002/ajh.23805. Epub 2014 Aug 4.

32.

Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.

Burnett AL, Anele UA, Trueheart IN, Strouse JJ, Casella JF.

Am J Med. 2014 Jul;127(7):664-8. doi: 10.1016/j.amjmed.2014.03.019. Epub 2014 Mar 25.

33.

Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN, Kwiatkowski JL, Roach ES, Kirkham FJ, Casella JF, DeBaun MR.

J Pediatr. 2014 May;164(5):1175-1180.e1. doi: 10.1016/j.jpeds.2014.01.001. Epub 2014 Feb 13.

34.

Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Sadreameli SC, Reller ME, Bundy DG, Casella JF, Strouse JJ.

Pediatr Blood Cancer. 2014 May;61(5):875-8. doi: 10.1002/pbc.24887. Epub 2014 Jan 31.

35.

Parent education and biologic factors influence on cognition in sickle cell anemia.

King AA, Strouse JJ, Rodeghier MJ, Compas BE, Casella JF, McKinstry RC, Noetzel MJ, Quinn CT, Ichord R, Dowling MM, Miller JP, Debaun MR.

Am J Hematol. 2014 Feb;89(2):162-7. doi: 10.1002/ajh.23604.

36.

Genome-wide meta-analysis of systolic blood pressure in children with sickle cell disease.

Bhatnagar P, Barron-Casella E, Bean CJ, Milton JN, Baldwin CT, Steinberg MH, Debaun M, Casella JF, Arking DE.

PLoS One. 2013 Sep 13;8(9):e74193. doi: 10.1371/journal.pone.0074193. eCollection 2013.

37.

Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia.

Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD; BABY HUG Investigators.

Pediatrics. 2013 Oct;132(4):677-83. doi: 10.1542/peds.2013-0333. Epub 2013 Sep 2.

38.

Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.

Bean CJ, Boulet SL, Yang G, Payne AB, Ghaji N, Pyle ME, Hooper WC, Bhatnagar P, Keefer J, Barron-Casella EA, Casella JF, Debaun MR.

Br J Haematol. 2013 Oct;163(2):268-76. doi: 10.1111/bjh.12507. Epub 2013 Aug 16.

39.

Partial manual exchange reduces iron accumulation during chronic red cell transfusions for sickle cell disease.

Savage WJ, Reddoch S, Wolfe J, Casella JF.

J Pediatr Hematol Oncol. 2013 Aug;35(6):434-6. doi: 10.1097/MPH.0b013e31829d470d.

40.

Validation of the sickle cell disease pain burden interview-youth.

Zempsky WT, O'Hara EA, Santanelli JP, Palermo TM, New T, Smith-Whitley K, Casella JF.

J Pain. 2013 Sep;14(9):975-82. doi: 10.1016/j.jpain.2013.03.007. Epub 2013 May 20.

41.

Association between baseline fetal hemoglobin levels and incidence of severe vaso-occlusive pain episodes in children with sickle cell anemia.

Bhatnagar P, Keefer JR, Casella JF, Barron-Casella EA, Bean CJ, Hooper CW, Payne AB, Arking DE, Debaun MR.

Pediatr Blood Cancer. 2013 Oct;60(10):E125-7. doi: 10.1002/pbc.24588. Epub 2013 May 15.

42.

Thrombospondin-1 and L-selectin are associated with silent cerebral infarct in children with sickle cell anaemia.

Faulcon LM, Fu Z, Dulloor P, Barron-Casella E, Savage W, Jennings JM, Van Eyk JE, Debaun M, Casella JF, Everett A.

Br J Haematol. 2013 Aug;162(3):421-4. doi: 10.1111/bjh.12374. Epub 2013 May 14. No abstract available.

43.

Daily changes in pain, mood and physical function in children hospitalized for sickle cell disease pain.

Zempsky WT, Palermo TM, Corsi JM, Lewandowski AS, Zhou C, Casella JF.

Pain Res Manag. 2013 Jan-Feb;18(1):33-8.

44.

Developmental function in toddlers with sickle cell anemia.

Armstrong FD, Elkin TD, Brown RC, Glass P, Rana S, Casella JF, Kalpatthi RV, Pavlakis S, Mi Z, Wang WC; Baby Hug Investigators.

Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.

45.

High rates of recurrent biliary tract obstruction in children with sickle cell disease.

Amoako MO, Casella JF, Strouse JJ.

Pediatr Blood Cancer. 2013 Apr;60(4):650-2. doi: 10.1002/pbc.24413. Epub 2012 Dec 19.

46.

Acute silent cerebral ischemic events in children with sickle cell anemia.

Quinn CT, McKinstry RC, Dowling MM, Ball WS, Kraut MA, Casella JF, Dlamini N, Ichord RN, Jordan LC, Kirkham FJ, Noetzel MJ, Roach ES, Strouse JJ, Kwiatkowski JL, Hirtz D, DeBaun MR.

JAMA Neurol. 2013 Jan;70(1):58-65. doi: 10.1001/jamaneurol.2013.576.

47.

Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

Bean CJ, Boulet SL, Ellingsen D, Pyle ME, Barron-Casella EA, Casella JF, Payne AB, Driggers J, Trau HA, Yang G, Jones K, Ofori-Acquah SF, Hooper WC, DeBaun MR.

Blood. 2012 Nov 1;120(18):3822-8. doi: 10.1182/blood-2011-06-361642. Epub 2012 Sep 10.

48.

Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia.

Thangarajh M, Yang G, Fuchs D, Ponisio MR, McKinstry RC, Jaju A, Noetzel MJ, Casella JF, Barron-Casella E, Hooper WC, Boulet SL, Bean CJ, Pyle ME, Payne AB, Driggers J, Trau HA, Vendt BA, Rodeghier M, DeBaun MR.

Br J Haematol. 2012 Nov;159(3):352-9. doi: 10.1111/bjh.12034. Epub 2012 Sep 7.

49.

Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.

Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, Garrett M, Hooper WC, Bean CJ, Debaun MR, Arking DE, Bhatnagar P, Casella JF, Keefer JR, Barron-Casella E, Gordeuk V, Kato GJ, Minniti C, Taylor J, Campbell A, Luchtman-Jones L, Hoppe C, Gladwin MT, Zhang Y, Steinberg MH.

Blood. 2012 Aug 30;120(9):1961-2. doi: 10.1182/blood-2012-06-432849. No abstract available.

50.

A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia.

Milton JN, Sebastiani P, Solovieff N, Hartley SW, Bhatnagar P, Arking DE, Dworkis DA, Casella JF, Barron-Casella E, Bean CJ, Hooper WC, DeBaun MR, Garrett ME, Soldano K, Telen MJ, Ashley-Koch A, Gladwin MT, Baldwin CT, Steinberg MH, Klings ES.

PLoS One. 2012;7(4):e34741. doi: 10.1371/journal.pone.0034741. Epub 2012 Apr 27.

Supplemental Content

Loading ...
Support Center